<DOC>
	<DOC>NCT00650936</DOC>
	<brief_summary>The purpose of this study is to prospectively evaluate the incidence of hemodynamic compromise and to obtain long-term survival data on patients with the AMPLATZER Septal Occluder</brief_summary>
	<brief_title>Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects, Atrial</mesh_term>
	<criteria>Patients must meet all inclusion criteria. A patient meets inclusion criteria if he/she: is indicated for implantation with the AMPLATZER Septal Occluder for occlusion of a secundum atrial septal defect (Note: This does not include the indication for closure of a fenestration following a fenestrated Fontan procedure), is willing and able to complete the followup requirements of this study, and signs the informed consent (or a legal representative signs the informed consent).</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Atrial</keyword>
	<keyword>Septal</keyword>
	<keyword>Defect</keyword>
</DOC>